Evidence map›Paper›PMID 20708051›Full record

ReviewAdvanced drug delivery reviews2010

Nuclear receptors in stem cells and their therapeutic potential.

GuoQiang Sun, Yanhong Shi

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Molecular Changes Associated with Suicide.International journal of molecular sciences · 2023
    Review
  4. The Journal of biological chemistry · 2018
    Article
  5. Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

GuoQiang SunDepartment of Neurosciences, Center for Gene Expression and Drug Discovery, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA.
Yanhong Shi
City of Hope · US

Funding

Orphan nuclear receptor TLX signaling in neural stem cellsR01NS059546 · NINDS · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI SHI, YANHONG · 2007 to 2010
$1.6M
Derivation of human pluripotent stem cells using small moleculesRC1NS068370 · NINDS · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI SHI, YANHONG · 2010 to 2010
$1.0M
NINDS NIH HHS R01 NS059546NINDS NIH HHS RC1 NS068370
6 · The paper itself

Abstract

The core transcriptional regulatory circuitries are important for controlling stem cell self-renewal and differentiation. Nuclear receptors provide an ideal model to regulate gene expression in both ligand-dependent and ligand-independent manners. Recent studies of regulatory events by nuclear receptors in neural stem cells, embryonic stem cells, and induced pluripotent stem cells (iPSCs) provided unique insights into mechanisms of stem cell regulation and provided invaluable resources for regenerative medicine. Nuclear receptors have been shown to be key players in stem cell self-renewal, pluripotency, and reprogramming. We summarize recent progress of studies on nuclear receptors in stem cell field as well as the potential therapeutic implications of these nuclear receptors and their cognate ligands. These studies not only uncover molecular mechanisms of stem cell regulation, but also provide unique opportunities for drug discovery.

Indexed as

Cell DifferentiationDrug DiscoveryEmbryonic Stem CellsGene Expression RegulationHumansInduced Pluripotent Stem CellsMolecular Targeted TherapyNeural Stem CellsPluripotent Stem CellsReceptors, Cytoplasmic and NuclearSignal TransductionStem CellsReceptors, Cytoplasmic and Nuclear

Identifiers

PMID20708051
PMCPMC2991409
OpenAlexW1985991976

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.